Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunotherapy|May 21, 2016
Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitorsManuela Terranova-Barberio, Scott Thomas, Pamela N Munster
Plastic and Reconstructive Surgery|August 26, 2017
Autologous Fat Grafting as a Novel Antiestrogen Vehicle for the Treatment of Breast CancerScott Thomas, Stephanie Chen, Hani Sbitany, et al.
Oncotarget|January 27, 2018
HDAC inhibition potentiates immunotherapy in triple negative breast cancerManuela Terranova-Barberio, Scott Thomas, Niwa Ali, et al.
Free Radical Biology & Medicine|September 28, 2015
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathwayAlessandra Leone, Maria Serena Roca, Chiara Ciardiello, et al.
Scientific Reports|January 10, 2018
Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancerJeenah Park, Scott Thomas, Allison Y Zhong, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 8, 2017
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53Manuela Terranova-Barberio, Biagio Pecori, Maria Serena Roca, et al.
Journal of Translational Medicine|February 20, 2025
The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomesFederica Torricelli, Filomena Spada, Cynthia Bishop, et al.
Oncotarget|January 7, 2016
Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expressionManuela Terranova-Barberio, Maria Serena Roca, Andrea Ilaria Zotti, et al.
Clinical and Experimental Immunology|January 12, 2022
Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patientsPanagiotis Karagiannis, Isabel Correa, Jitesh Chauhan, et al.
Nature Communications|July 19, 2020
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancerManuela Terranova-Barberio, Nela Pawlowska, Mallika Dhawan, et al.
Pageof 3